Cooperation PEP-Thérapy

Posted on 15-06-2015

The Fournier-Majoie Foundation cooperates with the biotech firm PEP-Thérapy that develops targeted therapies against cancer. 

As a matter of fact, PEP-Thérapy, which is a spin-off of the Institut Curie (Paris), cooperates with two Belgian entities: the company Biogazelle (Ghent) and the team of Professor Amant of the KU Leuven (Gasthuisberg).

Download pdf